Efficacy, Safety and Tolerability Study of APL-130277 for the Acute Treatment of OFF Episodes in Patients With Parkinson's Disease

Columbia University Medical Center - Neurological Institute, Movement Disorders, New York

Jefferson University Hospital Philadelphia, Philadelphia

MedStar Georgetown University Hospital, Washington D.C.

Johns Hopkins University, Baltimore

University of Virginia, Adult Neurology, Charlottesville

Wake Forest Baptist Health, Winston-Salem

Raleigh Neurology Associates, P.A., Raleigh

Emory University Department of Neurology, Atlanta

University of Miami, Miller School of Medicine, Miami

Parkinsons Disease and Movement Disorders Center, Boca Raton

USF Parkinson's Disease and Movement Disorder Center, Tampa

Parkinson's Disease Treatment Center of Southwest Florida, Port Charlotte

University of Alabama, Birmingham, Birmingham

University of Kentucky, Lexington

Cleveland Clinic, Cleveland

University of Cincinnati, Cincinnati

Henry Ford Hospital, West Bloomfield

QUEST Research Institute, Farmington Hills

Northern Michigan Neurology, Traverse City

Central DuPage Hospital - Neurodegenerative Clinic - Movement Disorders Center, Winfield

Northwestern University, Chicago

Rush University Medical Center, Chicago

Kansas University Medical Center - Department of Neurology, Kansas City

The Movement Disorder Clinic of Oklahoma, Tulsa

Movement Disorders Center of Arizona, Scottsdale

Mayo Clinic Arizona, Scottsdale

Keck Medical Center at USC, Los Angeles

The Research Center of Southern California, Oceanside

UC Irvine Health Gottschalk Medical Plaza, Irvine

The Parkinson's and Movement Disorder Institute, Fountain Valley

Evergreen Health, Kirkland

Muhammed Ali Parkinson and Movement Disorder CenterBarrow Neurological, Phoenix

UHN Toronto Western Hospital, Toronto